Indianapolis Business Journal

FEBRUARY 11-17, 2013

This week, meet the creative sisters at the helm of local snack sensation Just Pop In! and find out why the state will spend $281 million on a 27-mile stretch of Interstate 69. In Focus, read about why some local convention promoters think Indianapolis is losing its competitive edge. And Greg Andrews takes a look at the Marsh family's downfall.

Front PageBack to Top

Hospitals paying big to snag surgeons

Across the four largest hospital systems in central Indiana, six physicians received more than $1 million in compensation in 2011 while two others received more than $900,000 and nine others received $700,000 or more, according to the hospitals’ most recent reports to the IRS.

Read More

Ballard won’t levy charter fee, despite fiscal squeeze

Mayor Greg Ballard is nationally recognized as a rigorous charter authorizer, picky about which schools open and willing to shut down the under-performers. But there is a cost to the city’s education work and Ballard may have to consider how much of it can be supported by the city’s maxed-out general fund alone.

Read More

Top StoriesBack to Top

I-69 leg gobbling up state’s road funding

As legislators brace for a $250 million annual transportation spending gap down the road, the Indiana Department of Transportation has designated more than one-third of its entire federal highway aid this year toward building 27 miles of Interstate 69 between Crane and Bloomington.

Read More

Sisters put sophisticated spin on popcorn

Just Pop In! retail stores feature traditional, popular flavors like caramel and cheddar—and an “Indy Style” mixture of the two—but a dizzying array of more imaginative concoctions sets the local chain apart.

Read More

Community taps Walgreens for health reform help

In the era of health care reform, hospitals will face two new challenges: They will need to run higher-volume, lower-margin businesses, and they’ll be on the hook financially for what patients do even when they’re not receiving health care. Community Health Network’s new partnership with Walgreens’ Take Care Clinics is designed to help address both issues.

Read More

FocusBack to Top

OpinionBack to Top

MORRIS: Post office is cutting back, but IBJ isn’t

You’ve seen the news coverage. Starting in August, the United States Postal Service will discontinue Saturday mail delivery. Forget the bills. Forget the junk mail. Who cares if you have to wait until Monday to get those items? In fact, studies have shown that seven out of 10 Americans are fine with eliminating Saturday mail delivery.

Read More

KENNEDY: Pence should retake Regulation 101

New year, new governor, same song. One of the first official pronouncements from newly inaugurated Gov. Pence was a solemnly delivered promise to stop regulating—to cease issuing administrative rules except when "absolutely necessary."

Read More

Buses, yes, but no rail

I support fully the improvement of the bus system in the metro area [Morris column, Jan. 28]. It is a necessity and the responsibility of government to provide access to those who need this service efficiently and cost effectively.

Read More

Don’t expand vouchers

I say no to expansion of Indiana’s school voucher program, already the most liberal in the nation when it comes to taking public money and moving it to private—mostly religious—schools. I ask the Legislature, particularly the GOP super-majority, to do more for the “system of common schools” they promised to support when they swore to uphold Indiana’s Constitution.

Read More

Cursive is antiquated

In a political climate where jobs is the watchword of every campaign, I am confused and saddened by the state Senate Education Committee’s 7-4 vote endorsing a bill that would mandate the teaching of cursive writing in elementary school.

Read More

In BriefBack to Top

Lilly aims to submit five new drugs for approval

With Eli Lilly and Co. set to see patents expire on its best-selling drug at year’s end, it is in the company’s interest to say its pipeline is about to produce new drugs. But the Indianapolis drugmaker may be in a position to submit five new drugs for regulatory approval this year.

Read More